Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Red Blood Cell Transfusion: 2023 AABB International Guidelines.
Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, Cohn CS, Dubon A, Grossman BJ, Gupta GK, Hess AS, Jacobson JL, Kaplan LJ, Lin Y, Metcalf RA, Murphy CH, Pavenski K, Prochaska MT, Raval JS, Salazar E, Saifee NH, Tobian AAR, So-Osman C, Waters J, Wood EM, Zantek ND, Pagano MB. Carson JL, et al. Among authors: wood em. JAMA. 2023 Nov 21;330(19):1892-1902. doi: 10.1001/jama.2023.12914. JAMA. 2023. PMID: 37824153
Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions? Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.
Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, Norfolk D, Powter G, Littlewood T, Wood EM, Murphy MF; TOPPS Study Group. Stanworth SJ, et al. Among authors: wood em. Transfus Med Rev. 2010 Jul;24(3):163-71. doi: 10.1016/j.tmrv.2009.11.002. Transfus Med Rev. 2010. PMID: 20656185 Review.
A no-prophylaxis platelet-transfusion strategy for hematologic cancers.
Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, Norfolk D, Copplestone A, Smith N, Kerr P, Jones G, Raj K, Westerman DA, Szer J, Jackson N, Bardy PG, Plews D, Lyons S, Bielby L, Wood EM, Murphy MF; TOPPS Investigators. Stanworth SJ, et al. Among authors: wood em. N Engl J Med. 2013 May 9;368(19):1771-80. doi: 10.1056/NEJMoa1212772. N Engl J Med. 2013. PMID: 23656642 Free article. Clinical Trial.
Transfusing blood safely and appropriately.
Murphy MF, Waters JH, Wood EM, Yazer MH. Murphy MF, et al. Among authors: wood em. BMJ. 2013 Jul 16;347:f4303. doi: 10.1136/bmj.f4303. BMJ. 2013. PMID: 23861410 Review. No abstract available.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt LJ, Crighton GL, Wood EM, Stanworth S, Trivella M, Doree C, Tinmouth A, Murphy MF. Estcourt LJ, et al. Among authors: wood em. Cochrane Database Syst Rev. 2014;(3):CD010981. doi: 10.1002/14651858.CD010981. Cochrane Database Syst Rev. 2014. PMID: 25722649 Free PMC article. Updated.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. Crighton GL, et al. Among authors: wood em. Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD010981. doi: 10.1002/14651858.CD010981.pub2. Cochrane Database Syst Rev. 2015. PMID: 26422767 Free PMC article. Review.
297 results